Author

Ming O. Li

Memorial Sloan Kettering Cancer CenterORCID 0000-0002-1383-0535Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

Xian ZhangiD· 2 shared Alan Y. Baez VazqueziD· 1 shared Alexander O. ManniD· 1 shared Alicia LaiiD· 1 shared Andrew E. CornishiD· 1 shared Bharath SallaiD· 1 shared Carla F. KimiD· 1 shared Chaucie Edwards· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Xian ZhangORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologySciencePeer-reviewedJul 10, 2025

Macrophages control pathological interferon responses during viral respiratory infection

Daisy A. Hoagland, Patricia Rodríguez-Morales, Alexander O. Mann…·Ruth A. Franklin

This study identifies macrophage-derived Oncostatin M as a critical regulator of type I interferon responses during viral respiratory infection, preventing excessive inflammation.

40 citationstop 1%

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 3, 2024

Onco-Circuit Addiction and Onco-Nutrient mTORC1 Signaling Vulnerability in a Model of Aggressive T Cell Malignancy

Xinxin Wang, Andrew E. Cornish, Mytrang Do…·Ming O. Li

The paper shows that mTORC1 signaling hypersensitivity to leucine drives an onco-circuit in T cell malignancy, and a low leucine diet is therapeutic without impairing T cell immunity.

DOI 10.1101/2024.04.03.587917

mousebulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintNov 29, 2023

Activating neutrophils by co-administration of immunogenic recombinant modified vaccinia virus Ankara and granulocyte colony-stimulating factor for the treatment of malignant peripheral nerve sheath tumor

Yueqi Wang, Shuaitong Liu, Juan Yan…·Liang Deng

This study shows that co-administering immunogenic MVA and G-CSF activates neutrophils to kill MPNST tumors in a murine model.

DOI 10.1101/2023.11.29.569123

mouseexperimental assay

𝕏 PostBluesky